Sequence-Dependent Antiproliferative Effects of Gefitinib and Docetaxel on Non-Small Cell Lung Cancer (NSCLC) Cells and the Possible Mechanism

PURPOSE: Recent clinical trials showed that the sequential combination of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) and chemotherapy could prolong the PFS and/or OS of advanced non-small cell lung cancer (NSCLC) patients with EGFR mutation. The aim of present study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Bei, Zheng, Jingxian, Zeng, Yunyun, Li, Baofeng, Xie, Bo, Zheng, Jihua, Zhou, Juan, Zhang, Weimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256223/
https://www.ncbi.nlm.nih.gov/pubmed/25474307
http://dx.doi.org/10.1371/journal.pone.0114074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256223/
https://www.ncbi.nlm.nih.gov/pubmed/25474307
http://dx.doi.org/10.1371/journal.pone.0114074

Ejemplares similares